Ann: US FDA requests further data for VivaGel BV approval, page-155

First 155 Last

Share
Profile

Follow
Joelsmith2452

2,276 Posts.

331

27/05/22

09:41

Post #: 61653808
Share

Originally posted by chrisnj: ↑

Whether this is due to the quality of the product or the quality of the company that is selling the product, I do not know.....Joel there can be no doubt it's the quality of the company. I'm surprised they haven't done major renovations at HQ including several chimney stacks to allow the hot air to escape and floor grating to allow the BS to pass through.

Case study. Not SPL's - mine!

Sept 22 2017: Dep Docetaxal enters Ph 2 trials
Nov 29 2017: When asked at the AGM JF stated clearly that the Ph 2 trial would take up to 2 years as they shifted trial sites to the UK from Australia where more participants were available for recruitment.

It is now 3 months away from 5 years with JF recently changing expected completion from eofy to eocy bringing up her 4th amendment to the completion dates.

If the results where as compelling as JF would have you believe this product would surely have been licenced out by now. The only conclusion l can reach due to the lack of transparency from the building with the chimney stacks and floor grates is that the results are insufficient to interest a licencee and they are now scrambling to pull some in. We may end up in another Mundipharma scenario.

I am struggling to come to terms how this company offering so much promise has delivered so little whilst talking so big.

Expand

I could not agree more!

The thing that I am now afraid of is that maybe Jackie F's real skills lie in the creation of hype, via these announcements that get released and reel all of us investors in, because to date, that is all this company has really achieved............. HYPE

If someone can prove me wrong, have at it....

SPL Price at posting: 76.5¢ Sentiment: Hold Disclosure: Held
3 Upvote

1 Great analysis

Reply

Top Stories

HVN

Harvey Norman clocks subdued gains as Echo Law's junk warranty class action kicks off

PAR

FDA hands Paradigm Biopharma guidance to re-jig phase 3 osteo trial – or is it a delay?

CXU

Cauldron discovers shallow uranium up to 2km at WA's Yanrey

88E

HotCopper users smell capital raising as 88 Energy says "significant update" at Phoenix

BPM

BPM Minerals hits high-grade gold at the Claw Project WA; shares jump 86%

There are more pages in this discussion • 4 more messages in this thread...

First 155 Last

Add SPL (ASX) to my watchlist

(20min delay)
Last 9.8¢		Change 0.001(1.03%)		Mkt cap ! $41.73M

Open	High	Low	Value	Volume
9.9¢	10.5¢	9.8¢	$13.05K	130.9K

Buyers (Bids)

No.	Vol.	Price($)
2	46826	9.8¢

Sellers (Offers)

Price($)	Vol.	No.
10.0¢	69981	3

View Market Depth

No.	Vol.	Price($)
2	46826	0.098
4	865495	0.097
1	50000	0.096
3	176316	0.095
3	150000	0.094

Price($)	Vol.	No.
0.100	69981	3
0.105	90878	3
0.110	210058	7
0.115	122327	4
0.120	59907	7

Last trade - 13.20pm 18/09/2024 (20 minute delay)

SPL (ASX) Chart

Ann: US FDA requests further data for VivaGel BV approval, page-155

Harvey Norman clocks subdued gains as Echo Law's junk warranty class action kicks off

FDA hands Paradigm Biopharma guidance to re-jig phase 3 osteo trial – or is it a delay?

Cauldron discovers shallow uranium up to 2km at WA's Yanrey

HotCopper users smell capital raising as 88 Energy says "significant update" at Phoenix

BPM Minerals hits high-grade gold at the Claw Project WA; shares jump 86%

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: US FDA requests further data for VivaGel BV approval, page-155

Top Stories

Harvey Norman clocks subdued gains as Echo Law's junk warranty class action kicks off

FDA hands Paradigm Biopharma guidance to re-jig phase 3 osteo trial – or is it a delay?

Cauldron discovers shallow uranium up to 2km at WA's Yanrey

HotCopper users smell capital raising as 88 Energy says "significant update" at Phoenix

BPM Minerals hits high-grade gold at the Claw Project WA; shares jump 86%

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News